Skip to content

Clinical trials

Completed Hypertension, Pulmonary trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Status: Completed Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20061
20081
20094
20103
20121
20161
20191
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Seoul National University Hospital2
United Therapeutics2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Actelion1
Gachon University Gil Medical Center1
Konkuk University Medical Center1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary17
Pulmonary Arterial Hypertension7
Cardiovascular Diseases1
Connective Tissue Diseases1
Dyspnea1
Familial Primary Pulmonary Hypertension1
Heart Septal Defects, Ventricular1
Hypertension1
Lung Diseases1
Mitral Valve Insufficiency1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.